Work

1384P Phase II study of cabozantinib in patients with MET-altered lung cancers

Year: 2023

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.2417

Authors: G. Harada, F.C. Santini, R.W. Repetti, J. Chang, S.R. Yang, Y-T. Lin, K.A. Moses, C. Falcon, C.J. Wilhelm, M. Goldstein, A. Makhnin, M.S. Ginsberg, A.J. Plodkowski, M.G. Kris, A. Drilon

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387825518

FWCI:

Cites:

Cited by:

Related to: 10